Home Entertainment News Ayuso to open experimental brain neurotechnology institute

Ayuso to open experimental brain neurotechnology institute

25
0
Ayuso to open experimental brain neurotechnology institute

The president of the Community of Madrid, Isabel Diaz Ayusowill create the Experimental Institute of Neurotechnology for Brain Health which will house the Isabel Zendal Care Hospital in 2026. This complex will be used to further research into neurodegenerative diseases such as dementia, Parkinson’s or Alzheimer’s.

The Government Council of the Community of Madrid approved the draft General Finance Law for 2025, which marks a new historic record by touching the 30 billion euros. Thus, investments that strengthen the quality of its public services in the areas of health, education, housing, transport and social policies will be increased. The budget dedicated to Health also marks a historic record reaching 10,459 million euros, which represents 294 million (2.9%) more than the previous year.

Madrid is the European region with the highest life expectancy, at 85.2 years. For this reason, it is essential to advance in this area to add life to years and not just years to life, health sources said.

To facilitate study and scientific progress in this area, the Regional Executive will provide the Hospital nurse Isabel Zendal cutting-edge devices for research and medical diagnosis of neurodegenerative pathologies. To do this, it will integrate cutting-edge equipment, such as very high-field magnetic resonance imaging, which will optimize the analysis of this type of disease and its early detection. Its implementation, as well as the incorporation of biomedical engineering and Artificial intelligencewill improve patient care.

Thus, as the Minister of Health of the Community of Madrid announced this Thursday, Fatima Matutewill be a complex focused on deepening research into neurodegenerative diseases to improve the health of Madrid residents. “A complete center for processing, research and dissemination of knowledge“, he stressed.

The head of the Madrid Health Department recalled that she will join the Functional Neurohabilitation Center which will be inaugurated in Zendal in the spring of next year for the recovery of neurological and spinal injuries in children and adults.

“Within this monographic group intended to deal with brain health, we are going to have an Institute of Experimental Neurotenology and what we hear, given that we are the region that lives the longest, we are going to work on delayed dependency, dementia and that we have the capacity not only with therapies, with stimulations, but also with the research done there, to examine the brain to obtain people with more years of life but more independent and with better health physical and cerebral,” he explained.

In this sense, he emphasized that it will include “physical and also mental health” and clarified that they will function as “mixed centers where there is helpwhere there is teaching and where there is research because the ones feed off the others and are also enriched by the professionals.

“We will start with the theme of dementia, Alzheimer’s disease and other catastrophes, but we will continue with this whole wonderful world of the brain that Ramón y Cajal said were butterflies that flew and that one day they were hoping to tell us. what was going on in our minds,” he explained during an Executive Forum meeting.

At the forefront

Furthermore, the Regional Executive will equip Pavilion 3 of Zendal with cutting-edge research and technology equipment. medical diagnosis of neurodegenerative pathologies.

Thus, it will include cutting-edge machines, such as very high field magnetic resonance imaging which will make it possible to optimize the analysis of this type of diseases and their early detection. Its implementation, along with the integration of biomedical engineering and artificial intelligence, will improve patient care.

These resources will complement the service already provided since last April in this hospital through the Daycare for the Amyotrophic lateral sclerosis (ALS) and has treated 83 patients to date, in addition to training and supporting their families and caregivers.

Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here